Background: Vitamin D regulates many aspects of cellular growth and differentiation
in normal and cancer cells. There is growing evidence for both serum vitamin D
level and VDR gene polymorphism as prognostic factors in hematologic
malignancies. Aim of this work: Evaluation of vitamin D serum level and
VDR FOKI polymorphism as prognostic factors in adult AML patients. Patients & Methods: Eighty
subjects were included in this study, 50 adult patients with newly diagnosed AML
and 30 apparently healthy controls matched for age and sex. Venous blood
samples were withdrawn from all subjects for measurement of serum 25(OH)
vitamin Dusing competitive photo chemiluminescence and molecular detection of VDR (FOKI) polymorphism, which was done byRFLP PCR. All patients received the standard
induction chemotherapy regimen 3&7.Results: The rate ofvitamin
D insufficiency was significantly higher in AML patients compared to controls
(58% vs 16%, p = 0.03). The mutant FOKI genotype (FF & Ff) was found in 52
% of patients compared to 23 % of controls (p = 0.02). Patient with sufficient
vitamin D level showed a significantly higher complete response rate compared
to those with insufficient level (90% vs 44%, p = 0.02), while none of the
other clinical features showed significant relation. Patients with wild type
FOKI polymorphism (FF) were more likely to have favorable cytogenetics, while
patient with mutant FOKI polymorphism
References
[1]
Döhner, H., Weisdorf, D.J. and Bloomfield, C.D. (2015) Acute Myeloid Leukemia. The New England Journal of Medicine, 373, 1136-1152.
https://doi.org/10.1056/NEJMra1406184
[2]
Hwang, K., Park, C.G. and Jang, S. (2012) Flow Cytometric Quantification and Immunophenotyping of Leukemic Stem Cells in Acute Myeloid Leukemia. Annals of Hematology, 91, 1541-1546. https://doi.org/10.1007/s00277-012-1501-7
[3]
Pezeshki, S.M.S., Asnafi, A.A., Khosravi, A., Shahjahani, M., Azizidoost, S. and Shahrabi, S. (2018) Vitamin D and Its Receptor Polymorphisms: New Possible Prognostic Biomarkers in Leukemias. Oncology Reviews, 12, 366.
https://doi.org/10.4081/oncol.2018.366
[4]
Kulling, P.M., Olson, K.C., Olson, T.L., et al. (2018) Calcitriol-Mediated Reduction in IFN-γ Output in T Cell Large Granular Lymphocytic Leukemia Requires Vitamin D Receptor Upregulation. The Journal of Steroid Biochemistry and Molecular Biology, 177, 140-148. https://doi.org/10.1016/j.jsbmb.2017.07.009
[5]
Seyedalipour, F., Mansouri, A., Vaezi, M., et al. (2017) High Prevalence of Vitamin D Deficiency in Newly Diagnosed Acute Myeloid Leukemia Patients and Its Adverse Outcome. International Journal of Hematology-Oncology and Stem Cell Research, 11, 209-216.
[6]
Esfahani, A. and Ghoreishi, Z. (2016) Is There Any Association between Vitamin D Receptor Polymorphisms and Acute Myeloid Leukaemia? Annals of Oncology, 27, 313-327. https://doi.org/10.1093/annonc/mdw375.33
[7]
Haussler, M.R., Whitfield, G.K., Kaneko, I., Haussler, C.A., et al. (2013) Molecular Mechanisms of Vitamin D Action. Calcified Tissue International, 92, 77-98.
https://doi.org/10.1007/s00223-012-9619-0
[8]
Bobilev, I., Novik, V., Levi, I., Shpilberg, O., et al. (2011) The NrF2 Transcription Factor Is a Positive Regulator of Myeloid Differentiation of Acute Myeloid Leukemia Cells. Cancer Biology and Therapy, 11, 317-392.
https://doi.org/10.4161/cbt.11.3.14098
[9]
Elkerdany, T.A., Eissaa, D.G. and Moussa, M.M. (2014) Serum 25-Hydroxyvitamin D Levels in Relation to Disease Status and Prognosis in Acute Myeloid Leukemia. Egyptian Journal of Haematology, 39, 47-51.
https://doi.org/10.4103/1110-1067.139757
[10]
Munker, R., Norman, A.W. and Koeffler, H.P. (1986) Vitamin D Compounds: Effect on Clonal Proliferation and Differentiation of Human Myeloid Cells. Journal of Clinical Investigation, 78, 424-430. https://doi.org/10.1172/JCI112593
[11]
Lappe, M., Travers-Gustafson, D., Davies, K.M., Recker, R.R., et al. (2007) Vitamin D and Calcium Supplementation Reduces Cancer Risk: Results of a Randomized Trial. The American Journal of Clinical Nutrition, 85, 1586-1591.
https://doi.org/10.1093/ajcn/85.6.1586
[12]
Thomas, X., Chelghoumy, Y., Fanari, N. and Cannas, G. (2011) Serum 25-Hydroxyvitamin D Levels Are Associated with Prognosis in Hematological Malignancies. Hematology, 16, 278-283.
https://doi.org/10.1179/102453311X13085644679908
[13]
Vashi, P.G., Carolyn, A.L., Donald, B. and Gupta, D. (2011) Serum 25-Hydroxyvitamin D Is Inversely Associated with Body Mass Index in Cancer. Nutrition Journal, 10, 10-51. https://doi.org/10.1186/1475-2891-10-51
[14]
Wortsman, J., Matsuoka, L.Y., Chen, T.C., Lu, Z., et al. (2007) Decreased Bioavavlability of Vitamin D in Obesity. The American Journal of Clinical Nutrition, 72, 69.
[15]
Ibrahim, Y.A., Ali, E.W., Babiker, E.A. and Mohamed, M.A. (2015) Association of Vitamin D Receptor (VDR) Start Codon FokI Polymorphism with Acute Myelogenous Leukemia. European Academic Research, 2, 15474-15482.
[16]
Elzehery, R.R., Baiomy, A.A., Maf, H., Fares, R., et al. (2016) Vitamin D Status, Receptor Gene BsmI (A/G) Polymorphism and Breast Cancer in a Group of Egyptian Females. Egyptian Journal of Medical Human Genetics, 18, 269-273.
https://doi.org/10.1016/j.ejmhg.2016.11.003
[17]
Lee, H.J., Josephia, R.M., Tan, W., Hu, Q., et al. (2014) Low 25(OH) Vitamin D3 Levels Are Associated with Adverse Outcome in Newly-Diagnosed Intensively-Treated Adult Acute Myeloid Leukemia. Journal of US National Library of Medicine National Institutes of Health, 120, 521-529. https://doi.org/10.1002/cncr.28368
[18]
Ma, Y., Johnson, C.S. and Trump, D.L. (2016) Chapter Sixteen—Mechanistic Insights of Vitamin D Anticancer Effects. Vitamins and Hormones, 100, 395-431.
https://doi.org/10.1016/bs.vh.2015.11.003
[19]
Alizadeh, N., Khalili, H., Mohammadi, M., et al. (2015) Serum Vitamin D levels at Admission Predict the Length of Intensive Care Unit Stay But not In-Hospital Mortality of Critically ill Surgical Patients. Journal of Research in Pharmacy Practice, 4, 193-198. https://doi.org/10.4103/2279-042X.167051
[20]
Debant, M., Hemon, P., Brigaudeau, C., et al. (2015) Calcium Signaling and Cell Fate: How Can Ca2+ Signals Contribute to Wrong Decisions for Chronic Lymphocytic Leukemic B Lymphocyte Outcome? The International Journal of Developmental Biology, 59, 379-378. https://doi.org/10.1387/ijdb.150204om
